Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29365305/ below:

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

Affiliations

• ¹ From the Institute for Clinical Evaluative Sciences (J.C.K., K.L.S., M.A.C., H.C., D.T.K., L.C.R.), Public Health Ontario (J.C.K., K.L.S., N.S.C., L.C.R., J.B.G.), Dalla Lana School of Public Health (J.C.K., K.L.S., N.S.C., A.J.M., L.C.R.), and the Departments of Family and Community Medicine (J.C.K.) and Laboratory Medicine and Pathobiology (N.S.C., K.K., A.J.M., A.S., J.B.G.), University of Toronto, University Health Network (J.C.K.), North York General Hospital (K.K.), Sunnybrook Health Sciences Centre (D.T.K., A.S.), Sinai Health System (A.J.M.), and the Hospital for Sick Children (J.B.G.), Toronto, Children's Hospital of Eastern Ontario (T.K., D.M.) and the Department of Pathology and Laboratory Medicine, University of Ottawa (T.K.), Ottawa, William Osler Health System, Brampton, ON (D.C.R.), McMaster University, Hamilton, ON (M.S.), London Health Sciences Centre, London, ON (G.Z.), and the Newfoundland and Labrador Public Health Laboratory, St. John's (G.Z.) - all in Canada.

• PMID: 29365305
• DOI: 10.1056/NEJMoa1702090

Item in Clipboard

Jeffrey C Kwong et al. N Engl J Med. 2018.

• ¹ From the Institute for Clinical Evaluative Sciences (J.C.K., K.L.S., M.A.C., H.C., D.T.K., L.C.R.), Public Health Ontario (J.C.K., K.L.S., N.S.C., L.C.R., J.B.G.), Dalla Lana School of Public Health (J.C.K., K.L.S., N.S.C., A.J.M., L.C.R.), and the Departments of Family and Community Medicine (J.C.K.) and Laboratory Medicine and Pathobiology (N.S.C., K.K., A.J.M., A.S., J.B.G.), University of Toronto, University Health Network (J.C.K.), North York General Hospital (K.K.), Sunnybrook Health Sciences Centre (D.T.K., A.S.), Sinai Health System (A.J.M.), and the Hospital for Sick Children (J.B.G.), Toronto, Children's Hospital of Eastern Ontario (T.K., D.M.) and the Department of Pathology and Laboratory Medicine, University of Ottawa (T.K.), Ottawa, William Osler Health System, Brampton, ON (D.C.R.), McMaster University, Hamilton, ON (M.S.), London Health Sciences Centre, London, ON (G.Z.), and the Newfoundland and Labrador Public Health Laboratory, St. John's (G.Z.) - all in Canada.

• PMID: 29365305
• DOI: 10.1056/NEJMoa1702090

Item in Clipboard

Background: Acute myocardial infarction can be triggered by acute respiratory infections. Previous studies have suggested an association between influenza and acute myocardial infarction, but those studies used nonspecific measures of influenza infection or study designs that were susceptible to bias. We evaluated the association between laboratory-confirmed influenza infection and acute myocardial infarction.

Methods: We used the self-controlled case-series design to evaluate the association between laboratory-confirmed influenza infection and hospitalization for acute myocardial infarction. We used various high-specificity laboratory methods to confirm influenza infection in respiratory specimens, and we ascertained hospitalization for acute myocardial infarction from administrative data. We defined the "risk interval" as the first 7 days after respiratory specimen collection and the "control interval" as 1 year before and 1 year after the risk interval.

Results: We identified 364 hospitalizations for acute myocardial infarction that occurred within 1 year before and 1 year after a positive test result for influenza. Of these, 20 (20.0 admissions per week) occurred during the risk interval and 344 (3.3 admissions per week) occurred during the control interval. The incidence ratio of an admission for acute myocardial infarction during the risk interval as compared with the control interval was 6.05 (95% confidence interval [CI], 3.86 to 9.50). No increased incidence was observed after day 7. Incidence ratios for acute myocardial infarction within 7 days after detection of influenza B, influenza A, respiratory syncytial virus, and other viruses were 10.11 (95% CI, 4.37 to 23.38), 5.17 (95% CI, 3.02 to 8.84), 3.51 (95% CI, 1.11 to 11.12), and 2.77 (95% CI, 1.23 to 6.24), respectively.

Conclusions: We found a significant association between respiratory infections, especially influenza, and acute myocardial infarction. (Funded by the Canadian Institutes of Health Research and others.).

PubMed Disclaimer

• Mehr Herzinfarkte während der Grippe.

  Holzgreve H. Holzgreve H. MMW Fortschr Med. 2018 Feb;160(3):33. doi: 10.1007/s15006-018-0190-0. MMW Fortschr Med. 2018. PMID: 29464629 German. No abstract available.

• Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

  Waxman DA, Kanzaria HK, Schriger DL. Waxman DA, et al. N Engl J Med. 2018 Jun 28;378(26):2538-9. doi: 10.1056/NEJMc1805679. N Engl J Med. 2018. PMID: 29952170 No abstract available.

• Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

  Wiessman M, Shlomai A. Wiessman M, et al. N Engl J Med. 2018 Jun 28;378(26):2539. doi: 10.1056/NEJMc1805679. N Engl J Med. 2018. PMID: 29952171 No abstract available.

• Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

  Castillo-Rodriguez E, Fernandez-Prado R, Ortiz A. Castillo-Rodriguez E, et al. N Engl J Med. 2018 Jun 28;378(26):2539. doi: 10.1056/NEJMc1805679. N Engl J Med. 2018. PMID: 29952173 No abstract available.

• Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

  Buckley LF. Buckley LF. N Engl J Med. 2018 Jun 28;378(26):2539-40. doi: 10.1056/NEJMc1805679. N Engl J Med. 2018. PMID: 29952174 No abstract available.

• Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

  Cuervo G, Viasus D, Carratalà J. Cuervo G, et al. N Engl J Med. 2018 Jun 28;378(26):2540. doi: 10.1056/NEJMc1805679. N Engl J Med. 2018. PMID: 29952175 No abstract available.

• Laboratory-confirmed influenza infection and acute myocardial infarction among United States senior Veterans.

  Young-Xu Y, Smith J, Mahmud SM, Van Aalst R, Thommes EW, Neupane N, Lee JKH, Chit A. Young-Xu Y, et al. PLoS One. 2020 Dec 11;15(12):e0243248. doi: 10.1371/journal.pone.0243248. eCollection 2020. PLoS One. 2020. PMID: 33306675 Free PMC article.

• Influenza Infection and Acute Myocardial Infarction.

  de Boer AR, Riezebos-Brilman A, van Hout D, van Mourik MSM, Rümke LW, de Hoog MLA, Vaartjes I, Bruijning-Verhagen PCJL. de Boer AR, et al. NEJM Evid. 2024 Jul;3(7):EVIDoa2300361. doi: 10.1056/EVIDoa2300361. Epub 2024 Jun 25. NEJM Evid. 2024. PMID: 38916418

• Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland.

  Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Warren-Gash C, et al. Eur Respir J. 2018 Mar 29;51(3):1701794. doi: 10.1183/13993003.01794-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29563170 Free PMC article.

• [Influenza infection and risk of myocardial infarction: the protective effect of influenza vaccination. One more reason to vaccinate].

  Coutsoumbas GV, Di Pasquale G. Coutsoumbas GV, et al. G Ital Cardiol (Rome). 2018 Nov;19(11):620-627. doi: 10.1714/3012.30109. G Ital Cardiol (Rome). 2018. PMID: 30425391 Review. Italian.

• Influenza virus and atherosclerosis.

  Peretz A, Azrad M, Blum A. Peretz A, et al. QJM. 2019 Oct 1;112(10):749-755. doi: 10.1093/qjmed/hcy305. QJM. 2019. PMID: 30605546 Review.

• The Global Trend of Drug Resistant Sites in Influenza A Virus Neuraminidase Protein from 2011 to 2020.

  Wang J, Shen B, Yue L, Xu H, Chen L, Qian D, Dong W, Hu Y. Wang J, et al. Microorganisms. 2024 Oct 12;12(10):2056. doi: 10.3390/microorganisms12102056. Microorganisms. 2024. PMID: 39458365 Free PMC article.

• Elucidation of the inhibitory activity of ivermectin with host nuclear importin α and several SARS-CoV-2 targets.

  Bello M. Bello M. J Biomol Struct Dyn. 2022 Nov;40(18):8375-8383. doi: 10.1080/07391102.2021.1911857. Epub 2021 Apr 10. J Biomol Struct Dyn. 2022. PMID: 33843474 Free PMC article.

• Influenza vaccination for heart failure patients: a cost-effectiveness analysis from the perspective of Chinese healthcare system.

  Zhao M, Liu F, Wang L, Chen D. Zhao M, et al. Front Public Health. 2024 Aug 9;12:1348207. doi: 10.3389/fpubh.2024.1348207. eCollection 2024. Front Public Health. 2024. PMID: 39185111 Free PMC article.

• Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic.

  Lantelme P, Couray Targe S, Metral P, Bochaton T, Ranc S, Le Bourhis Zaimi M, Le Coanet A, Courand PY, Harbaoui B. Lantelme P, et al. Arch Cardiovasc Dis. 2020 Jun-Jul;113(6-7):443-447. doi: 10.1016/j.acvd.2020.06.001. Epub 2020 Jun 25. Arch Cardiovasc Dis. 2020. PMID: 32636131 Free PMC article.

• Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity.

  Cornelissen A, Kutyna M, Cheng Q, Sato Y, Kawakami R, Sakamoto A, Kawai K, Mori M, Fernandez R, Guo L, Pellegrini D, Guagliumi G, Barakat M, Virmani R, Finn A. Cornelissen A, et al. Cardiovasc Revasc Med. 2022 Feb;35:129-138. doi: 10.1016/j.carrev.2021.03.023. Epub 2021 Apr 8. Cardiovasc Revasc Med. 2022. PMID: 33863660 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3